1. Home
  2. ELEV vs GENK Comparison

ELEV vs GENK Comparison

Compare ELEV & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELEV
  • GENK
  • Stock Information
  • Founded
  • ELEV 2019
  • GENK 2011
  • Country
  • ELEV United States
  • GENK United States
  • Employees
  • ELEV N/A
  • GENK N/A
  • Industry
  • ELEV Biotechnology: Pharmaceutical Preparations
  • GENK Restaurants
  • Sector
  • ELEV Health Care
  • GENK Consumer Discretionary
  • Exchange
  • ELEV Nasdaq
  • GENK Nasdaq
  • Market Cap
  • ELEV 37.6M
  • GENK 36.5M
  • IPO Year
  • ELEV 2021
  • GENK 2023
  • Fundamental
  • Price
  • ELEV $0.61
  • GENK $5.51
  • Analyst Decision
  • ELEV Buy
  • GENK Strong Buy
  • Analyst Count
  • ELEV 6
  • GENK 3
  • Target Price
  • ELEV $7.20
  • GENK $13.17
  • AVG Volume (30 Days)
  • ELEV 1.3M
  • GENK 65.2K
  • Earning Date
  • ELEV 03-05-2025
  • GENK 03-05-2025
  • Dividend Yield
  • ELEV N/A
  • GENK N/A
  • EPS Growth
  • ELEV N/A
  • GENK 483.78
  • EPS
  • ELEV N/A
  • GENK 0.17
  • Revenue
  • ELEV N/A
  • GENK $198,834,000.00
  • Revenue This Year
  • ELEV N/A
  • GENK $14.66
  • Revenue Next Year
  • ELEV N/A
  • GENK $21.47
  • P/E Ratio
  • ELEV N/A
  • GENK $31.98
  • Revenue Growth
  • ELEV N/A
  • GENK 12.50
  • 52 Week Low
  • ELEV $0.50
  • GENK $5.26
  • 52 Week High
  • ELEV $5.83
  • GENK $14.46
  • Technical
  • Relative Strength Index (RSI)
  • ELEV 43.44
  • GENK 31.30
  • Support Level
  • ELEV $0.64
  • GENK $5.26
  • Resistance Level
  • ELEV $0.72
  • GENK $5.73
  • Average True Range (ATR)
  • ELEV 0.05
  • GENK 0.35
  • MACD
  • ELEV -0.00
  • GENK 0.01
  • Stochastic Oscillator
  • ELEV 18.41
  • GENK 18.52

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

About GENK GEN Restaurant Group Inc.

GEN Restaurant Group Inc is an Asian casual dining restaurant in the United States. It offers an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables.

Share on Social Networks: